Profile
Theresa Janke is the founder of 4D Molecular Therapeutics, Inc. (founded in 2013) and holds the title of Chief of Staff.
Ms. Janke is also the founder of Ignite Immunotherapy, Inc. Ms. Janke's former job positions include Director-Clinical Research & Development at Celgene Corp.
(2013-2014), Director-Clinical Operations at SillaJen Biotherapeutics, Inc. (2007-2013), and Senior Director-Corporate Projects at SillaJen, Inc. (2013-2014).
Ms. Janke obtained her undergraduate degree from the University of California, Santa Barbara in 1996.
Theresa Janke active positions
| Companies | Position | Start |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Founder | 11/09/2013 |
Former positions of Theresa Janke
| Companies | Position | End |
|---|---|---|
Ignite Immunotherapy, Inc.
Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Designs and develops oncolytic virus vaccines | Founder | 30/09/2019 |
| SILLAJEN, INC. | Corporate Officer/Principal | 31/12/2013 |
| CELGENE | Chief Tech/Sci/R&D Officer | 31/12/2013 |
SillaJen Biotherapeutics, Inc.
SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company provides clinical research and development services | Chief Tech/Sci/R&D Officer | 31/12/2012 |
Training of Theresa Janke
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
SillaJen Biotherapeutics, Inc.
SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company provides clinical research and development services | Commercial Services |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SillaJen, Inc.
SillaJen, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapeutics | Health Technology |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Ignite Immunotherapy, Inc.
Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Designs and develops oncolytic virus vaccines | Health Technology |
- Stock Market
- Insiders
- Theresa Janke
















